Click for best price
Induced Pluripotent Stem Cells Market Size, Share 2022
Market Analysis and Insights: Global Induced Pluripotent Stem Cells Market
The global Induced Pluripotent Stem Cells market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Induced Pluripotent Stem Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Induced Pluripotent Stem Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Induced Pluripotent Stem Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Induced Pluripotent Stem Cells market.
Global Induced Pluripotent Stem Cells Scope and Market Size
Induced Pluripotent Stem Cells Production market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells Production market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Segment by Application
Academic Research
Drug Development
Toxicity Screening
Regenerative Medicine
By Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Induced Pluripotent Stem Cells product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Induced Pluripotent Stem Cells, with price, sales, revenue, and global market share of Induced Pluripotent Stem Cells from 2019 to 2022.
Chapter 3, the Induced Pluripotent Stem Cells competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Induced Pluripotent Stem Cells breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Induced Pluripotent Stem Cells market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Induced Pluripotent Stem Cells.
Chapter 13, 14, and 15, to describe Induced Pluripotent Stem Cells sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Induced Pluripotent Stem Cells Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Induced Pluripotent Stem Cells Production Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Induced Pluripotent Stem Cells Production Product Introduction
1.2 Market by Type
1.2.1 Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hepatocytes
1.2.3 Fibroblasts
1.2.4 Keratinocytes
1.2.5 Amniotic Cells
1.2.6 Others
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Academic Research
1.3.3 Drug Development
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Induced Pluripotent Stem Cells Production Sales Estimates and Forecasts 2017-2028
2.2 Global Induced Pluripotent Stem Cells Production Revenue Estimates and Forecasts 2017-2028
2.3 Global Induced Pluripotent Stem Cells Production Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Induced Pluripotent Stem Cells Production Sales by Region
2.4.1 Global Induced Pluripotent Stem Cells Production Sales by Region (2017-2022)
2.4.2 Global Sales Induced Pluripotent Stem Cells Production by Region (2023-2028)
2.5 Global Induced Pluripotent Stem Cells Production Revenue by Region
2.5.1 Global Induced Pluripotent Stem Cells Production Revenue by Region (2017-2022)
2.5.2 Global Induced Pluripotent Stem Cells Production Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Induced Pluripotent Stem Cells Production Sales by Manufacturers
3.1.1 Global Top Induced Pluripotent Stem Cells Production Manufacturers by Sales (2017-2022)
3.1.2 Global Induced Pluripotent Stem Cells Production Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Induced Pluripotent Stem Cells Production in 2021
3.2 Global Induced Pluripotent Stem Cells Production Revenue by Manufacturers
3.2.1 Global Induced Pluripotent Stem Cells Production Revenue by Manufacturers (2017-2022)
3.2.2 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Production Revenue in 2021
3.3 Global Induced Pluripotent Stem Cells Production Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Induced Pluripotent Stem Cells Production Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Induced Pluripotent Stem Cells Production Sales by Type
4.1.1 Global Induced Pluripotent Stem Cells Production Historical Sales by Type (2017-2022)
4.1.2 Global Induced Pluripotent Stem Cells Production Forecasted Sales by Type (2023-2028)
4.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
4.2 Global Induced Pluripotent Stem Cells Production Revenue by Type
4.2.1 Global Induced Pluripotent Stem Cells Production Historical Revenue by Type (2017-2022)
4.2.2 Global Induced Pluripotent Stem Cells Production Forecasted Revenue by Type (2023-2028)
4.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
4.3 Global Induced Pluripotent Stem Cells Production Price by Type
4.3.1 Global Induced Pluripotent Stem Cells Production Price by Type (2017-2022)
4.3.2 Global Induced Pluripotent Stem Cells Production Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Induced Pluripotent Stem Cells Production Sales by Application
5.1.1 Global Induced Pluripotent Stem Cells Production Historical Sales by Application (2017-2022)
5.1.2 Global Induced Pluripotent Stem Cells Production Forecasted Sales by Application (2023-2028)
5.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
5.2 Global Induced Pluripotent Stem Cells Production Revenue by Application
5.2.1 Global Induced Pluripotent Stem Cells Production Historical Revenue by Application (2017-2022)
5.2.2 Global Induced Pluripotent Stem Cells Production Forecasted Revenue by Application (2023-2028)
5.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
5.3 Global Induced Pluripotent Stem Cells Production Price by Application
5.3.1 Global Induced Pluripotent Stem Cells Production Price by Application (2017-2022)
5.3.2 Global Induced Pluripotent Stem Cells Production Price Forecast by Application (2023-2028)
6 North America
6.1 North America Induced Pluripotent Stem Cells Production Market Size by Type
6.1.1 North America Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
6.1.2 North America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
6.2 North America Induced Pluripotent Stem Cells Production Market Size by Application
6.2.1 North America Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
6.2.2 North America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
6.3 North America Induced Pluripotent Stem Cells Production Market Size by Country
6.3.1 North America Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
6.3.2 North America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells Production Market Size by Type
7.1.1 Europe Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
7.1.2 Europe Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
7.2 Europe Induced Pluripotent Stem Cells Production Market Size by Application
7.2.1 Europe Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
7.2.2 Europe Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
7.3 Europe Induced Pluripotent Stem Cells Production Market Size by Country
7.3.1 Europe Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
7.3.2 Europe Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Type
8.1.1 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
8.1.2 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
8.2 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Application
8.2.1 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
8.2.2 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
8.3 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Region
8.3.1 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2017-2028)
8.3.2 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells Production Market Size by Type
9.1.1 Latin America Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
9.1.2 Latin America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
9.2 Latin America Induced Pluripotent Stem Cells Production Market Size by Application
9.2.1 Latin America Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
9.2.2 Latin America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
9.3 Latin America Induced Pluripotent Stem Cells Production Market Size by Country
9.3.1 Latin America Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
9.3.2 Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Type
10.1.1 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Type (2017-2028)
10.1.2 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Type (2017-2028)
10.2 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Application
10.2.1 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Application (2017-2028)
10.2.2 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Application (2017-2028)
10.3 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Country
10.3.1 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2017-2028)
10.3.2 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Overview
11.1.3 Lonza Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lonza Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lonza Recent Developments
11.2 Axol Bioscience Ltd.
11.2.1 Axol Bioscience Ltd. Corporation Information
11.2.2 Axol Bioscience Ltd. Overview
11.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Axol Bioscience Ltd. Recent Developments
11.3 Evotec
11.3.1 Evotec Corporation Information
11.3.2 Evotec Overview
11.3.3 Evotec Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Evotec Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Evotec Recent Developments
11.4 Hitachi Ltd.
11.4.1 Hitachi Ltd. Corporation Information
11.4.2 Hitachi Ltd. Overview
11.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hitachi Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hitachi Ltd. Recent Developments
11.5 Merck KGaA
11.5.1 Merck KGaA Corporation Information
11.5.2 Merck KGaA Overview
11.5.3 Merck KGaA Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck KGaA Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck KGaA Recent Developments
11.6 REPROCELL Inc.
11.6.1 REPROCELL Inc. Corporation Information
11.6.2 REPROCELL Inc. Overview
11.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 REPROCELL Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 REPROCELL Inc. Recent Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Corporation Information
11.7.2 Fate Therapeutics Overview
11.7.3 Fate Therapeutics Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Fate Therapeutics Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fate Therapeutics Recent Developments
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Corporation Information
11.8.2 Thermo Fisher Scientific, Inc. Overview
11.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Thermo Fisher Scientific, Inc. Recent Developments
11.9 StemCellFactory III
11.9.1 StemCellFactory III Corporation Information
11.9.2 StemCellFactory III Overview
11.9.3 StemCellFactory III Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 StemCellFactory III Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 StemCellFactory III Recent Developments
11.10 Applied StemCell Inc.
11.10.1 Applied StemCell Inc. Corporation Information
11.10.2 Applied StemCell Inc. Overview
11.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Applied StemCell Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Induced Pluripotent Stem Cells Production Industry Chain Analysis
12.2 Induced Pluripotent Stem Cells Production Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Induced Pluripotent Stem Cells Production Production Mode & Process
12.4 Induced Pluripotent Stem Cells Production Sales and Marketing
12.4.1 Induced Pluripotent Stem Cells Production Sales Channels
12.4.2 Induced Pluripotent Stem Cells Production Distributors
12.5 Induced Pluripotent Stem Cells Production Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Induced Pluripotent Stem Cells Production Industry Trends
13.2 Induced Pluripotent Stem Cells Production Market Drivers
13.3 Induced Pluripotent Stem Cells Production Market Challenges
13.4 Induced Pluripotent Stem Cells Production Market Restraints
14 Key Findings in The Global Induced Pluripotent Stem Cells Production Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Hepatocytes
Table 3. Major Manufacturers of Fibroblasts
Table 4. Major Manufacturers of Keratinocytes
Table 5. Major Manufacturers of Amniotic Cells
Table 6. Major Manufacturers of Others
Table 7. Global Induced Pluripotent Stem Cells Production Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Induced Pluripotent Stem Cells Production Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Induced Pluripotent Stem Cells Production Sales by Region (2017-2022) & (K Units)
Table 10. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2017-2022)
Table 11. Global Induced Pluripotent Stem Cells Production Sales by Region (2023-2028) & (K Units)
Table 12. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2023-2028)
Table 13. Global Induced Pluripotent Stem Cells Production Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2017-2022)
Table 15. Global Induced Pluripotent Stem Cells Production Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2023-2028)
Table 17. Global Induced Pluripotent Stem Cells Production Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Induced Pluripotent Stem Cells Production Sales Share by Manufacturers (2017-2022)
Table 19. Global Induced Pluripotent Stem Cells Production Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Induced Pluripotent Stem Cells Production Revenue Share by Manufacturers (2017-2022)
Table 21. Induced Pluripotent Stem Cells Production Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Induced Pluripotent Stem Cells Production Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Induced Pluripotent Stem Cells Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Production as of 2021)
Table 24. Induced Pluripotent Stem Cells Production Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Induced Pluripotent Stem Cells Production Product Offered
Table 26. Date of Manufacturers Enter into Induced Pluripotent Stem Cells Production Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 29. Global Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 30. Global Induced Pluripotent Stem Cells Production Sales Share by Type (2017-2022)
Table 31. Global Induced Pluripotent Stem Cells Production Sales Share by Type (2023-2028)
Table 32. Global Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Induced Pluripotent Stem Cells Production Revenue Share by Type (2017-2022)
Table 35. Global Induced Pluripotent Stem Cells Production Revenue Share by Type (2023-2028)
Table 36. Induced Pluripotent Stem Cells Production Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Induced Pluripotent Stem Cells Production Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 39. Global Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 40. Global Induced Pluripotent Stem Cells Production Sales Share by Application (2017-2022)
Table 41. Global Induced Pluripotent Stem Cells Production Sales Share by Application (2023-2028)
Table 42. Global Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Induced Pluripotent Stem Cells Production Revenue Share by Application (2017-2022)
Table 45. Global Induced Pluripotent Stem Cells Production Revenue Share by Application (2023-2028)
Table 46. Induced Pluripotent Stem Cells Production Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Induced Pluripotent Stem Cells Production Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 49. North America Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 50. North America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 53. North America Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 54. North America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 57. North America Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 58. North America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 61. Europe Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 62. Europe Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 65. Europe Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 66. Europe Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 69. Europe Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 70. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2023-2028) & (US$ Million)
Table 108. Lonza Corporation Information
Table 109. Lonza Description and Major Businesses
Table 110. Lonza Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Lonza Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Lonza Recent Developments
Table 113. Axol Bioscience Ltd. Corporation Information
Table 114. Axol Bioscience Ltd. Description and Major Businesses
Table 115. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Axol Bioscience Ltd. Recent Developments
Table 118. Evotec Corporation Information
Table 119. Evotec Description and Major Businesses
Table 120. Evotec Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Evotec Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Evotec Recent Developments
Table 123. Hitachi Ltd. Corporation Information
Table 124. Hitachi Ltd. Description and Major Businesses
Table 125. Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Hitachi Ltd. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Hitachi Ltd. Recent Developments
Table 128. Merck KGaA Corporation Information
Table 129. Merck KGaA Description and Major Businesses
Table 130. Merck KGaA Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Merck KGaA Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Merck KGaA Recent Developments
Table 133. REPROCELL Inc. Corporation Information
Table 134. REPROCELL Inc. Description and Major Businesses
Table 135. REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. REPROCELL Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. REPROCELL Inc. Recent Developments
Table 138. Fate Therapeutics Corporation Information
Table 139. Fate Therapeutics Description and Major Businesses
Table 140. Fate Therapeutics Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Fate Therapeutics Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Fate Therapeutics Recent Developments
Table 143. Thermo Fisher Scientific, Inc. Corporation Information
Table 144. Thermo Fisher Scientific, Inc. Description and Major Businesses
Table 145. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Thermo Fisher Scientific, Inc. Recent Developments
Table 148. StemCellFactory III Corporation Information
Table 149. StemCellFactory III Description and Major Businesses
Table 150. StemCellFactory III Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. StemCellFactory III Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. StemCellFactory III Recent Developments
Table 153. Applied StemCell Inc. Corporation Information
Table 154. Applied StemCell Inc. Description and Major Businesses
Table 155. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Applied StemCell Inc. Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Induced Pluripotent Stem Cells Production Distributors List
Table 161. Induced Pluripotent Stem Cells Production Customers List
Table 162. Induced Pluripotent Stem Cells Production Market Trends
Table 163. Induced Pluripotent Stem Cells Production Market Drivers
Table 164. Induced Pluripotent Stem Cells Production Market Challenges
Table 165. Induced Pluripotent Stem Cells Production Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Induced Pluripotent Stem Cells Production Product Picture
Figure 3. Global Induced Pluripotent Stem Cells Production Market Share by Type in 2021 & 2028
Figure 3. Hepatocytes Product Picture
Figure 4. Fibroblasts Product Picture
Figure 5. Keratinocytes Product Picture
Figure 6. Amniotic Cells Product Picture
Figure 7. Others Product Picture
Figure 8. Global Induced Pluripotent Stem Cells Production Market Share by Application in 2021 & 2028
Figure 9. Academic Research
Figure 10. Drug Development
Figure 11. Toxicity Screening
Figure 12. Regenerative Medicine
Figure 13. Induced Pluripotent Stem Cells Production Report Years Considered
Figure 14. Global Induced Pluripotent Stem Cells Production Sales 2017-2028 (K Units)
Figure 15. Global Induced Pluripotent Stem Cells Production Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Induced Pluripotent Stem Cells Production Revenue 2017-2028 (US$ Million)
Figure 17. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2017-2022)
Figure 19. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2023-2028)
Figure 20. North America Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 21. North America Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Induced Pluripotent Stem Cells Production Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Induced Pluripotent Stem Cells Production Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Induced Pluripotent Stem Cells Production Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Induced Pluripotent Stem Cells Production in the World: Market Share by Induced Pluripotent Stem Cells Production Revenue in 2021
Figure 32. Global Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 34. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 35. Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 36. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 37. North America Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 38. North America Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 39. North America Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 40. North America Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 41. North America Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 42. North America Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 43. United States Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 46. Europe Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 47. Europe Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 48. Europe Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 49. Europe Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 50. Europe Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 51. Germany Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 52. France Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Induced Pluripotent Stem Cells Production Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Share by Region (2017-2028)
Figure 62. China Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 65. India Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 72. Latin America Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 74. Latin America Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 76. Latin America Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 77. Mexico Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Induced Pluripotent Stem Cells Production Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Induced Pluripotent Stem Cells Production Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Induced Pluripotent Stem Cells Production Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Induced Pluripotent Stem Cells Production Revenue Share by Country (2017-2028)
Figure 86. Turkey Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Induced Pluripotent Stem Cells Production Revenue (2017-2028) & (US$ Million)
Figure 89. Induced Pluripotent Stem Cells Production Value Chain
Figure 90. Induced Pluripotent Stem Cells Production Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
